<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Large Language Models in Cancer Genomics | Cristea Lab</title>
    <link rel="stylesheet" href="../styles.css">
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css">
    <style>
        .research-page {
            margin-top: 100px;
            padding: 3rem 0;
        }
        .research-hero {
            background: linear-gradient(135deg, var(--primary-color), var(--secondary-color));
            color: white;
            padding: 4rem 0;
            text-align: center;
            margin-bottom: 4rem;
        }
        .research-hero h1 {
            font-size: 3rem;
            margin-bottom: 1rem;
        }
        .research-hero p {
            font-size: 1.3rem;
            max-width: 800px;
            margin: 0 auto;
            opacity: 0.9;
        }
        .research-section {
            margin-bottom: 4rem;
        }
        .research-section h2 {
            font-size: 2.5rem;
            color: var(--primary-color);
            margin-bottom: 2rem;
            border-bottom: 3px solid var(--primary-color);
            padding-bottom: 0.5rem;
        }
        .project-card {
            background: white;
            border-radius: 15px;
            box-shadow: var(--shadow);
            padding: 2.5rem;
            margin-bottom: 2rem;
            border-left: 5px solid var(--accent-color);
            transition: var(--transition);
        }
        .project-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 15px 35px rgba(0, 0, 0, 0.15);
        }
        .project-card h3 {
            font-size: 1.8rem;
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .project-card h4 {
            font-size: 1.3rem;
            color: var(--accent-color);
            margin-bottom: 1rem;
            font-weight: 600;
        }
        .project-description {
            font-size: 1.1rem;
            line-height: 1.7;
            margin-bottom: 1.5rem;
        }
        .project-details {
            background: var(--bg-light);
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        .project-details h5 {
            color: var(--primary-color);
            margin-bottom: 1rem;
        }
        .methodology-list {
            list-style: none;
            padding: 0;
        }
        .methodology-list li {
            padding: 0.5rem 0;
            border-bottom: 1px solid #eee;
        }
        .methodology-list li:last-child {
            border-bottom: none;
        }
        .methodology-list li::before {
            content: 'ðŸ”¬';
            margin-right: 0.5rem;
        }
        .impact-highlight {
            background: linear-gradient(135deg, #f8f9fa, #e9ecef);
            padding: 2rem;
            border-radius: 15px;
            border-left: 5px solid var(--secondary-color);
            margin: 2rem 0;
        }
        .impact-highlight h4 {
            color: var(--secondary-color);
            margin-bottom: 1rem;
        }
        .collaboration-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin: 2rem 0;
        }
        .collaborator {
            background: white;
            padding: 1.5rem;
            border-radius: 10px;
            box-shadow: var(--shadow);
            text-align: center;
        }
        .tech-stack {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin: 1rem 0;
        }
        .tech-tag {
            background: var(--primary-color);
            color: white;
            padding: 0.3rem 0.8rem;
            border-radius: 15px;
            font-size: 0.9rem;
            font-weight: 500;
        }
        .figure-container {
            background: white;
            padding: 2rem;
            border-radius: 15px;
            box-shadow: var(--shadow);
            margin: 2rem 0;
            text-align: center;
        }
        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 10px;
        }
        .figure-caption {
            font-style: italic;
            color: var(--text-light);
            margin-top: 1rem;
            font-size: 0.95rem;
        }
    </style>
</head>
<body>
    <!-- Navigation -->
    <nav class="navbar">
        <div class="nav-container">
            <div class="nav-brand">
                <h1>Cristea Lab</h1>
                <span class="nav-subtitle">Computational Cancer Research</span>
            </div>
            <ul class="nav-menu">
                <li><a href="../index.html" class="nav-link">Home</a></li>
                <li><a href="../index.html#research" class="nav-link">Research</a></li>
                <li><a href="../team.html" class="nav-link">Team</a></li>
                <li><a href="../publications.html" class="nav-link">Publications</a></li>
                <li><a href="../index.html#software" class="nav-link">Software</a></li>
                <li><a href="../index.html#contact" class="nav-link">Contact</a></li>
            </ul>
            <div class="nav-toggle">
                <span class="bar"></span>
                <span class="bar"></span>
                <span class="bar"></span>
            </div>
        </div>
    </nav>

    <!-- Research Page Content -->
    <div class="research-page">
        <!-- Hero Section -->
        <div class="research-hero">
            <div class="container">
                <h1>Large Language Models in Cancer Genomics</h1>
                <p>
                    Pioneering the application of generative AI and transformer architectures to understand 
                    and generate cancer progression patterns, revolutionizing how we analyze single-cell genomics data 
                    and predict clinical responses in oncology.
                </p>
            </div>
        </div>

        <div class="container">
            <!-- Overview -->
            <div class="research-section">
                <h2>Research Overview</h2>
                <div class="project-description">
                    Our lab is at the forefront of developing and applying Large Language Models (LLMs) specifically designed for cancer genomics. 
                    We leverage the power of transformer architectures and generative AI to tackle some of the most challenging problems in 
                    computational oncology. Our approach treats genomic data as a language, where genes are words, cells are sentences, 
                    and cancer progression becomes a narrative that we can both understand and predict.
                </div>
                
                <div class="impact-highlight">
                    <h4>Revolutionary Impact</h4>
                    <p>
                        This research represents a paradigm shift in cancer genomics, enabling zero-shot prediction of cancer evolution, 
                        mechanistic interpretability of tumor progression, and the generation of synthetic cancer progression data for 
                        therapeutic development. Our models are the first to successfully apply natural language processing techniques 
                        to single-cell cancer genomics at scale.
                    </p>
                </div>
            </div>

            <!-- Project A: LLMs in Genomics -->
            <div class="research-section">
                <h2>Project A: Multi-modal LLMs for Genomics</h2>
                <div class="project-card">
                    <h3>Foundation Models for Multi-omics Integration</h3>
                    <div class="project-description">
                        We are developing the next generation of foundation models that can simultaneously process and integrate 
                        multiple types of genomic data - transcriptomics, proteomics, and epigenomics - within a unified transformer 
                        architecture. This represents a significant advancement over current single-modality approaches.
                    </div>
                    
                    <div class="project-details">
                        <h5>Technical Approach</h5>
                        <ul class="methodology-list">
                            <li>Multi-modal transformer architecture with cross-attention mechanisms</li>
                            <li>Custom tokenization strategies for different omics data types</li>
                            <li>Self-supervised pre-training on large-scale cancer genomics datasets</li>
                            <li>Fine-tuning for downstream tasks including drug response prediction</li>
                        </ul>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">PyTorch</span>
                        <span class="tech-tag">Transformers</span>
                        <span class="tech-tag">Hugging Face</span>
                        <span class="tech-tag">Single-cell RNA-seq</span>
                        <span class="tech-tag">Proteomics</span>
                        <span class="tech-tag">Multi-modal Learning</span>
                    </div>

                    <div class="project-details">
                        <h5>Key Innovation</h5>
                        <p>
                            Our multi-modal architecture can learn shared representations across different biological data types, 
                            enabling the model to make predictions even when some data modalities are missing - a common challenge 
                            in clinical settings.
                        </p>
                    </div>
                </div>
            </div>

            <!-- Project B: evoCancerGPT -->
            <div class="research-section">
                <h2>Project B: evoCancerGPT - Zero-shot Cancer Evolution</h2>
                <div class="project-card">
                    <h3>Generating Cancer Progression with Generative AI</h3>
                    <div class="project-description">
                        evoCancerGPT is our flagship large language model specifically designed to understand and generate cancer 
                        evolutionary trajectories. Using a decoder-only transformer architecture, the model can predict the next 
                        steps in cancer progression given initial cellular states.
                    </div>

                    <div class="figure-container">
                        <div style="background: #f8f9fa; padding: 3rem; border-radius: 10px; border: 2px dashed var(--primary-color);">
                            <i class="fas fa-chart-line" style="font-size: 4rem; color: var(--primary-color); margin-bottom: 1rem;"></i>
                            <p style="color: var(--primary-color); font-weight: 600;">evoCancerGPT Architecture Diagram</p>
                            <p style="font-size: 0.9rem; color: var(--text-light);">Decoder-only transformer with MLP layers for sparse expression matrices</p>
                        </div>
                        <div class="figure-caption">
                            Figure: Overview of evoCancerGPT architecture showing data preprocessing pipeline, sentence construction 
                            from 4096 tokens representing cells in pseudotime order, and transformer architecture with extra MLP layers 
                            to handle sparse scRNA-seq data and non-linear relationships.
                        </div>
                    </div>

                    <div class="project-details">
                        <h5>Model Architecture</h5>
                        <ul class="methodology-list">
                            <li>Decoder-only transformer with 4096 token context length</li>
                            <li>Evolutionary sentences constructed in increasing pseudotime order</li>
                            <li>Extra MLP layers before and after transformer blocks</li>
                            <li>Specialized handling of sparse expression matrices</li>
                            <li>Zero-shot generation capabilities for unseen cancer types</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Training Data & Performance</h5>
                        <p>
                            The model is trained on comprehensive single-cell RNA sequencing datasets from multiple cancer types, 
                            enabling it to learn universal patterns of cancer evolution. In validation studies, evoCancerGPT 
                            successfully generated realistic cancer progression trajectories that matched known biological patterns 
                            and predicted novel evolutionary pathways validated by experimental follow-up.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">GPT Architecture</span>
                        <span class="tech-tag">Pseudotime Analysis</span>
                        <span class="tech-tag">Zero-shot Learning</span>
                        <span class="tech-tag">Cancer Evolution</span>
                        <span class="tech-tag">scRNA-seq</span>
                    </div>
                </div>
            </div>

            <!-- Project C: Clinical Trial Data -->
            <div class="research-section">
                <h2>Project C: LLM Applications in Clinical Trial Data</h2>
                <div class="project-card">
                    <h3>Foundation Models for Real-World Cancer Clinical Data</h3>
                    <div class="project-description">
                        We evaluate and apply state-of-the-art foundation models like scGPT to real-world single nucleus RNA 
                        sequencing data from ongoing clinical trials at the Hale Center for Pancreatic Cancer. This work bridges 
                        the gap between research models and clinical applications.
                    </div>

                    <div class="project-details">
                        <h5>Clinical Trial Integration</h5>
                        <ul class="methodology-list">
                            <li>Analysis of Paricalcitol clinical trial data (Vitamin D receptor agonist)</li>
                            <li>Pre-treatment and post-treatment single nucleus RNA sequencing</li>
                            <li>Foundation model fine-tuning on clinical genomics data</li>
                            <li>Biomarker discovery for treatment response prediction</li>
                            <li>Integration with clinical outcome data</li>
                        </ul>
                    </div>

                    <div class="figure-container">
                        <div style="background: #f8f9fa; padding: 3rem; border-radius: 10px; border: 2px dashed var(--accent-color);">
                            <i class="fas fa-hospital" style="font-size: 4rem; color: var(--accent-color); margin-bottom: 1rem;"></i>
                            <p style="color: var(--accent-color); font-weight: 600;">Clinical Trial Workflow</p>
                            <p style="font-size: 0.9rem; color: var(--text-light);">Paricalcitol trial with pre/post treatment analysis</p>
                        </div>
                        <div class="figure-caption">
                            Overview of the Paricalcitol clinical trial conducted at the Hale Center, evaluating the effect of 
                            Paricalcitol (vitamin D receptor agonist) combined with gemcitabine and albumin-bound paclitaxel 
                            in metastatic pancreatic cancer patients.
                        </div>
                    </div>

                    <div class="impact-highlight">
                        <h4>Clinical Impact</h4>
                        <p>
                            This work directly impacts patient care by providing clinicians with AI-powered tools to predict 
                            treatment responses and identify patients most likely to benefit from specific therapies. Our models 
                            have shown superior performance compared to traditional biomarkers in predicting clinical outcomes.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">scGPT</span>
                        <span class="tech-tag">Clinical Genomics</span>
                        <span class="tech-tag">Biomarker Discovery</span>
                        <span class="tech-tag">Treatment Response</span>
                        <span class="tech-tag">snRNA-seq</span>
                    </div>
                </div>
            </div>

            <!-- Project D: Reinforcement Learning -->
            <div class="research-section">
                <h2>Project D: Reinforcement Learning Enhanced LLMs</h2>
                <div class="project-card">
                    <h3>RLHF for Single Cell Genomics Tasks</h3>
                    <div class="project-description">
                        We implement reinforcement learning from human feedback (RLHF) techniques to improve LLM performance 
                        on single cell genomics tasks, particularly cell type annotation. This approach, inspired by our 
                        collaboration with DeepSeek-R1, enhances model reasoning capabilities.
                    </div>

                    <div class="project-details">
                        <h5>Reinforcement Learning Framework</h5>
                        <ul class="methodology-list">
                            <li>Human feedback integration for cell type annotation quality</li>
                            <li>Reward model training based on expert biological knowledge</li>
                            <li>Policy optimization for improved reasoning chains</li>
                            <li>Multi-step reasoning for complex cell state identification</li>
                            <li>Continuous learning from expert corrections</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Key Achievements</h5>
                        <p>
                            Our RLHF-enhanced models demonstrate significant improvements in cell type annotation accuracy, 
                            particularly for rare cell types and transitional states. The models also provide interpretable 
                            reasoning chains that help biologists understand the decision-making process.
                        </p>
                    </div>

                    <div class="tech-stack">
                        <span class="tech-tag">RLHF</span>
                        <span class="tech-tag">DeepSeek-R1</span>
                        <span class="tech-tag">Cell Type Annotation</span>
                        <span class="tech-tag">Reasoning Models</span>
                        <span class="tech-tag">Expert Knowledge</span>
                    </div>
                </div>
            </div>

            <!-- Key Publications & Software -->
            <div class="research-section">
                <h2>Publications & Software</h2>
                <div class="project-card">
                    <h3>Key Outputs</h3>
                    <div class="project-details">
                        <h5>Recent Publications</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>Tan et al.</strong> "Evaluating and Interpreting scGPT: a Foundation Model for Single-Cell Biology in Real-World Cancer Clinical Trial Data" - AACR Pancreatic Cancer 2024</li>
                            <li><strong>evoCancerGPT manuscript</strong> - In preparation for Nature Methods submission 2025</li>
                            <li><strong>Multi-modal foundation models review</strong> - Contributing to comprehensive survey paper</li>
                        </ul>
                    </div>

                    <div class="project-details">
                        <h5>Software & Tools</h5>
                        <ul style="list-style-type: disc; padding-left: 2rem;">
                            <li><strong>evoCancerGPT</strong> - Open-source implementation with pre-trained models</li>
                            <li><strong>Clinical LLM Pipeline</strong> - Tools for applying foundation models to clinical data</li>
                            <li><strong>Multi-modal Genomics Toolkit</strong> - Integration framework for omics data</li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- Collaborations -->
            <div class="research-section">
                <h2>Key Collaborations</h2>
                <div class="collaboration-grid">
                    <div class="collaborator">
                        <h4>Hale Center Teams</h4>
                        <p>Dr. Brian Wolpin, Dr. Andrew Aguirre, Dr. Jonathan Nowak</p>
                    </div>
                    <div class="collaborator">
                        <h4>Broad Institute</h4>
                        <p>AI/ML and Genomics Platform collaborations</p>
                    </div>
                    <div class="collaborator">
                        <h4>Industry Partners</h4>
                        <p>DeepSeek AI, leading tech companies</p>
                    </div>
                    <div class="collaborator">
                        <h4>Clinical Teams</h4>
                        <p>Oncology and pathology departments</p>
                    </div>
                </div>
            </div>

            <!-- Future Directions -->
            <div class="research-section">
                <h2>Future Directions</h2>
                <div class="impact-highlight">
                    <h4>Next Phase Developments</h4>
                    <p>
                        We are expanding our LLM work to include multi-modal cancer genomics foundation models that integrate 
                        transcriptomics, proteomics, and imaging data. Future developments include mechanistic interpretability 
                        methods for these architectures and the implementation of reinforcement learning techniques to improve 
                        model performance and establish the Hale Center as a leader in AI-driven cancer genomics research.
                    </p>
                </div>
            </div>

            <!-- Back Navigation -->
            <div class="text-center" style="margin-top: 3rem;">
                <a href="../index.html#research" class="btn btn-secondary">Back to Research Overview</a>
            </div>
        </div>
    </div>

    <!-- Footer -->
    <footer class="footer">
        <div class="container">
            <div class="footer-content">
                <div class="footer-logo">
                    <h3>Cristea Lab</h3>
                    <p>Computational Cancer Research</p>
                </div>
                <div class="footer-links">
                    <a href="https://www.dana-farber.org" target="_blank">Dana-Farber Cancer Institute</a>
                    <a href="https://www.harvard.edu" target="_blank">Harvard University</a>
                </div>
                <div class="footer-social">
                    <a href="#" class="social-link"><i class="fab fa-twitter"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-github"></i></a>
                    <a href="#" class="social-link"><i class="fab fa-linkedin"></i></a>
                </div>
            </div>
            <div class="footer-bottom">
                <p>&copy; 2024 Cristea Lab. All rights reserved.</p>
            </div>
        </div>
    </footer>

    <script src="../script.js"></script>
</body>
</html>